메뉴 건너뛰기




Volumn 21, Issue 5, 2013, Pages 1199-1208

9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: Optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro

Author keywords

(Phosphonomethoxy)propyl; Acyclic nucleoside phosphonates; Antivirals; HIV; PMPDAP; Prodrugs; Purine

Indexed keywords

1 [6 AMINO 2 [(2 HYDROXYPROPYL)AMINO] 9H PURIN 9 YL]PROPAN 2 OL; 1 [6 AMINO 2 [2 (HYDROXYPROPYL)AMINO] 9H PURIN 9 YL]PROPAN 2 OL; 9 (2 HYDROXYPROPYL) 2,6 DIAMINOPURINE; 9 (PROP 1 EN 1 YL) 9H PURINE 2,6 DIAMINE; 9 [2 (PHOSPHONOMETHOXY)PROPYL] 2,6 DIAMINOPURINE; 9 [2 (PHOSPHONOMETHOXY)PROPYL] N6 PHOSPHONOMETHYL 2,6 DIAMINOPURINE; ALKOXYLALKYL(HEXADECYLOXYPROPYL)MONOESTER; ANTIRETROVIRUS AGENT; BIS(HEXADECYLOXYPROPYL)ESTER; CARBONIC ACID; ETOMIDATE; HEXADECYLOXYPROPYL ESTER; N (6 AMINO 9 (2 HYDROXYPROPYL) 9H PURIN 2 YL)FORNAMIDE; PRODRUG; PROPANEDIOL CARBONATE; UNCLASSIFIED DRUG;

EID: 84873703456     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2012.12.044     Document Type: Article
Times cited : (15)

References (19)
  • 11
    • 84873724142 scopus 로고    scopus 로고
    • HIV drug resistence early warning indicators
    • HIV drug resistence early warning indicators. http://www.who.int/hiv/ topics/drugresistance/hiv-dr-early-warning-indicators.pdf.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.